Abstract: An anion-binding hydrophilic epichlorohydrin and 1-(3-aminopropyl)imidazole copolymeric bile acid sequestrant, pharmaceutical compositions thereof, and use thereof in the treatment of ailments or conditions in which a bile acid sequestrant and inhibitor of fat absorption is indicated.

Abstract: The tendency of an orally-ingestible dietary fiber composition to cause excessive flatulence upon oral administration is reduced considerably by the incorporation therein, in addition to other dietary fiber components, a flatulence-reducing amount of chitosan, or by administering such a flatulence-reducing amount of chitosan concurrently with the other dietary fiber components, illustratively the usual antihyperlipidemic pharmaceutical dietary fiber composition or dietary supplement composition. A preferred dietary fiber composition according to the invention incorporates a plurality of dietary fiber components other than chitosan, preferably acacia gum, pectin, and guar gum, together with a flatulence-reducing amount of chitosan.

Abstract: A method of treating irritable bowel syndrome, including diarrhea, constipation, and pain aspects thereof, in a human patient, whereby the method involves the step of orally administering to the human patient an amount of an anion-binding polymer and a hydrophilic polymer, either simultaneously, concurrently, or in the form of a pharmaceutical composition wherein the anion-binding polymer and the hydrophilic polymer alleviate irritable bowel syndrome.

Abstract: The application discloses a good-tasting and palatable gritty drug formulation, wherein the grittiness is associated as a part of a pleasurable organoleptic sensation, which contains a gritty and optionally bad-tasting or odoriferous drug and a seedy fibrous fruit, and optionally an aqueous medium and a gelling agent, and preferably also a sweetener and a flavoring agent, wherein the gritty drug is representatively an antihypercholesterolemic drug, especially a bile acid sequestrant, and particularly cholestyramine, a method for the preparation thereof, and a method of converting a gritty drug into a more readily-acceptable formulation which assists with patient compliance.

Abstract: An orally administrable composition and method for reducing serum cholesterol levels are disclosed. A pharmaceutical composition comprising guar gum, and a dispersing mineral salt such as, for example, calcium carbonate, magnesium carbonate, or potassium carbonate, is administered to humans to reduce serum cholesterol levels.

Abstract: An orally administrable composition and method for reducing serum cholesterol levels are disclosed. A pharmaceutical composition comprising a gel-forming fiber such as, for example, guar gum, pysllium seed, pectin, glucomannon, oat and barley and a mineral salt such as for example, calcium carbonate, magnesium carbonate and potassium carbonate is administered to humans to reduce serum cholesterol levels.

Abstract: A receive only, low cost, small size, frequency agile earth satellite ground station has the low noise amplifier, frequency agile receiver, head end modulator, motor control circuit and optional signal unscrambler disposed on circuit boards about a variable polarization antenna-to-low noise amplifier feed which together with the motor for controlling the feed polarization of the feed are all located in a weather insulating cannister at the focal point of the system antenna whereby the only elements of the system not located in the cannister are the antenna and a cable connected control console employed to select a desired channel and to select local or satellite reception located at the TV set. A motor control is provided which senses odd-or-even least significant bit of binary coded channel selection signals to determine if the feed polarization, control motor must be energized.

Abstract: The present specification relates to the antiatherosclerotic use of khellin and related furochromones, and further provides novel antiatherogenic furochromones.

Abstract: A pocket filter cartridge for removing solid particulates from a dirty gas stream including a plurality of sheath-like filter bags suspended from a common header assembly in side-by-side relation. Each of the filter bags includes a plurality of alternating rows of filamentary stays or span stitching spaced across the width of the bag and extending generally parallel to one another along its length so that upon inflation of the bag by the dirty gas stream during use, the stays shape the bag into a plurality of adjacent tube-like sections opening into one another within the bag. The stays in each row are sized to be of a different length than the stays in the rows adjacent to it to alternately vary the thickness of the bag at the juncture of the tube-like sections formed in the bag.

Abstract: A pocket filter cartridge having a plurality of side-by-side filter assemblies secured to a common mounting frame adapted to be secured across a dirty gas stream in a gas duct. Each of the filter assemblies includes a sheath-like filter bag suspended from an apertured header plate which is secured to the mounting frame in an overlapping fashion with its adjacent mounting plates to form a common header for all of the filters in the cartridge.

Abstract: A pocket filter cartridge including at least one sheath-like filter bag which is suspended from a mounting sleeve affixed to an apertured header plate disposed across a dirty gas stream by a retaining collar holding it in press-fit clamping relation to the mounting member.

Abstract: The present specification relates to the antiatherosclerotic use of khellin and related furochromones, and further provides novel antiatherogenic 6-halofurochromones.